- Release Date: 27/03/24 09:07
- Summary: Stage 2 Insights Confirm Diagnostic & Clinical Viability
- Price Sensitive: Yes
- Download Document 503.12KB
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.90 |
Change
-0.040(2.06%) |
Mkt cap ! $160.5M | |||
| Open | High | Low | Value | Volume |
| $1.87 | $1.90 | $1.86 | $22.66K | 12.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49 | $1.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.93 | 490 | 1 |
View Market Depth
| Last trade - 14.38pm 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.92 |
Change
-0.040 ( 0.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.87 | $1.93 | $1.86 | 3049 | ||
| Last updated 15.15pm 12/06/2024 ? | |||||
| EMV (ASX) Chart |